Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD

Journal of Clinical Epidemiology

Volumn 62, Issue 1, 2009, Pages 102-110

  Brozek, Jan L ^a,b,c   Guyatt, Gordon H ^d   Heels Ansdell, Diane ^d   Degl'Innocenti, Alessio ^e   Armstrong, David ^d   Fallone, Carlo A ^f   Wiklund, Ingela ^g   Veldhuyzen van Zanten, Sander ^h   Chiba, Naoki ^d,i   Barkun, Alan N ^f   Akl, Elie A ^j   Schünemann, Holger J ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c Polish Institute for Evidence Based Medicine   (Poland)

^d MCMASTER UNIVERSITY   (Canada)

^e ASTRAZENECA R AND D   (Sweden)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^g GLAXOSMITHKLINE   (United Kingdom)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ Surrey GI Clinic   (Canada)

^j UNIVERSITY AT BUFFALO   (United States)

more..

Author keywords

Gastroesophageal reflux disease; QOLRAD; Quality of life; Questionnaires; Responsiveness; Utility measure

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH SURVEY; HEARTBURN; HUMAN; JOB PERFORMANCE; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; STOMACH DISEASE; SYMPTOM; THERMOMETER; WORKING TIME;

ACTIVITIES OF DAILY LIVING; ADULT; ANTI-ULCER AGENTS; CANADA; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

EID: 57649101249     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2008.02.012     Document Type: Article

References (64)

1. Isolauri J., and Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 27 (1995) 67-70
2. Locke III G.R., Talley N.J., Fett S.L., Zinsmeister A.R., and Melton III L.J. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112 (1997) 1448-1456
3. Dimenas E., Carlsson G., Glise H., Israelsson B., and Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl 221 (1996) 8-13
4. Jones R., Horbach S., Sander P., and Ryden-Bergsten T. Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease. Pharmacoeconomics 21 (2003) 1091-1102
5. Dean B.B., Crawley J.A., Schmitt C.M., Wong J., and Ofman J.J. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther 17 (2003) 1309-1317
6. Henke C.J., Levin T.R., Henning J.M., and Potter L.P. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol 95 (2000) 788-792
7. Wahlqvist P., Carlsson J., Stalhammar N.O., and Wiklund I. Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)-results from a cross-sectional study. Value Health 5 (2002) 106-113
8. Wahlqvist P. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life. Am J Gastroenterol 96 8 Suppl (2001) S57-S61
9. Agreus L., and Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 20 (2002) 347-355
10. Nyren O., Adami H.O., Gustavsson S., Loof L., and Nyberg A. Social and economic effects of non-ulcer dyspepsia. Scand J Gastroenterol Suppl 109 (1985) 41-47
11. Guyatt G.H., King D.R., Feeny D.H., Stubbing D., and Goldstein R.S. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 52 (1999) 187-192
12. Colwell H.H., Mathias S.D., Pasta D.J., Henning J.M., and Hunt R.H. Development of a health-related quality-of-life questionnaire for individuals with gastroesophageal reflux disease: a validation study. Dig Dis Sci 44 (1999) 1376-1383
13. Coyne K.S., Wiklund I., Schmier J., Halling K., Degl' Innocenti A., and Revicki D. Development and validation of a disease-specific treatment satisfaction questionnaire for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 18 (2003) 907-915
14. Damiano A., Handley K., Adler E., Siddique R., and Bhattacharyja A. Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS). Dig Dis Sci 47 (2002) 1530-1537
15. Eypasch E., Williams J.I., Wood-Dauphinee S., Ure B.M., Schmulling C., Neuge bauer E., et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 82 (1995) 216-222
16. Locke G.R., Talley N.J., Weaver A.L., and Zinsmeister A.R. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 69 (1994) 539-547
17. Manterola C., Munoz S., Grande L., and Bustos L. Initial validation of a questionnaire for detecting gastroesophageal reflux disease in epidemiological settings. J Clin Epidemiol 55 (2002) 1041-1045
18. Pare P., Meyer F., Armstrong D., Pyzyk M., Pericak D., and Goeree R. Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease. Can J Gastroenterol 17 (2003) 307-312
19. Velanovich V., Vallance S.R., Gusz J.R., Tapia F.V., and Harkabus M.A. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 183 (1996) 217-224
20. Wiklund I.K., Junghard O., Grace E., et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 583 (1998) 41-49
21. Young T., Kirchdoerfer L., and Osterhaus J. A development and validation process for a disease-specific quality of life instrument. Drug Inf J 30 (1996) 185-193
22. Bennet K.J., and Torrrance G.W. Measuring health state preferences and utilities: rating scale, time trade-off, and standard gamble techniques. Quality of life and pharmacoeconomics in clinical trials. 2nd edition (1996), Lippincott, Williams and Wilkins, Philadelphia, PA 253-265
23. Torrance G.W. Measurement of health state utilities for economic appraisal. J Health Econ 5 (1986) 1-30
24. Holloway C.A. Decision making under uncertainty: models and choices Englewood Clilfs (1979), Prentice-Hall, NJ
25. Chakravorty I., Cayton R.M., and Szczepura A. Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome. Eur Respir J 20 (2002) 1233-1238
26. Hurskainen R., Teperi J., Rissanen P., Aalto A.M., Grenman S., Kivela A., et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 291 (2004) 1456-1463
27. Kalra L., Evans A., Perez I., Melbourn A., Patel A., Knapp M., et al. Training carers of stroke patients: randomised controlled trial. BMJ 328 7448 (2004) 1099
28. Schünemann H.J., Griffith L., Stubbing D., Goldstein R., and Guyatt G.H. A clinical trial to evaluate the measurement properties of 2 direct preference instruments administered with and without hypothetical marker states. Med Decis Making 23 (2003) 140-149
29. Wiebe S., Guyatt G., Weaver B., Matijevic S., and Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 56 (2003) 52-60
30. Katsura H., Yamada K., and Kida K. Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease. J Am Geriatr Soc 51 (2003) 1131-1135
31. Nishiyama O., Taniguchi H., Kondoh Y., Nishimura K., Suzuki R., Takagi K., et al. The effectiveness of the visual analogue scale 8 in measuring health-related quality of life for COPD patients. Respir Med 94 (2000) 1192-1199
32. Puhan M.A., Guyatt G.H., Goldstein R., Mador J., Mckim D., Stahl E., et al. Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Respir Med 101 (2007) 308-316
33. Korolija D., Sauerland S., Wood-Dauphinee S., Abbou C.C., Eypasch E., Caballero M.G., et al. Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery. Surg Endosc 18 (2004) 879-897
34. Fujiwara Y., Higuchi K., Nebiki H., Chono S., Uno H., Kitada K., et al. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 21 Suppl 2 (2005) 10-18
35. Pare P., Armstrong D., Pericak D., and Pyzyk M. Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine. J Clin Gastroenterol 37 (2003) 132-138
36. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
37. Wiklund I., Bardhan K.D., Muller-Lissner S., Bigard M.A., Bianchi Porro G., Ponce J., et al. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group. Ital J Gastroenterol Hepatol 30 (1998) 19-27
38. Kamolz T., Granderath P.A., Bammer T., Pasiut M., Wykypiel Jr. H., Herrmann R., et al. Mid- and long-term quality of life assessments after laparoscopic fundoplication and refundoplication: a single unit review of more than 500 antireflux procedures. Dig Liver Dis 34 (2002) 470-476
39. Mahon D., Rhodes M., Decadt B., Hindmarsh A., Lowndes R., Beckingham I., et al. Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux. Br J Surg 92 (2005) 695-699
40. Pleskow D., Rothstein R., Lo S., Hawes R., Kozarek R., Haber G., et al. Endoscopic full-thickness plication for the treatment of GERD: 12-month follow-up for the North American open-label trial. Gastrointest Endosc 61 (2005) 643-649
41. Velanovich V. Comparison of symptomatic and quality of life outcomes of laparoscopic versus open antireflux surgery. Surgery 126 (1999) 782-788 discussion 788-789
42. Schünemann H.J., Armstrong D., Degl'innocenti A., Wiklund I., Fallone C.A., Tanser L., et al. A randomized multicenter trial to evaluate simple utility elicitation techniques in patients with gastroesophageal reflux disease. Med Care 42 (2004) 1132-1142
43. van Pinxteren B., Numans M.E., Bonis P.A., and Lau J. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2 (2000) CD002095
44. Revicki D.A., Wood M., Wiklund I., and Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 7 (1998) 75-83
45. Kulich K.R., Wiklund I., and Junghard O. Factor structure of the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire evaluated in patients with heartburn predominant reflux disease. Qual Life Res 12 (2003) 699-708
46. Talley N.J., Fullerton S., Junghard O., and Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 96 (2001) 1998-2004
47. Wiklund I, Fullerton S, Junghard O, Talley N. Interpretability and meaningfulness of quality of life changes in patients with heartburn. Annual Meeting at Digestive Disease Week, the American Gastroenterological Association (AGA). San Diego, CA; 2000.
48. Reilly M.C., Zbrozek A.S., and Dukes E.M. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4 (1993) 353-365
49. Puhan M.A., Guyatt G.H., Armstrong D., Wiklund I., Fallone C.A., Heels-Ansdell D., et al. Validation of a symptom diary for patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 23 (2006) 531-541
50. Guyatt G.H., Feeny D.H., and Patrick D.L. Measuring health-related quality of life. Ann Intern Med 118 (1993) 622-629
51. Schünemann H.J., Griffith L., Jaeschke R., Goldstein R., Stubbing D., and Guyatt G.H. Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol 56 (2003) 1170-1176
52. Jaeschke R., Singer J., and Guyatt G.H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 10 (1989) 407-415
53. Katz J.N., Larson M.G., Phillips C.B., Fossel A.H., and Liang M.H. Comparative measurement sensitivity of short and longer health status instruments. Med Care 30 (1992) 917-925
54. Liang M.H., Fossel A.H., and Larson M.G. Comparisons of five health status instruments for orthopedic evaluation. Med Care 28 (1990) 632-642
55. Zou G.Y. Quantifying responsiveness of quality of life measures without an external criterion. Qual Life Res 14 (2005) 1545-1552
56. Beaton D.E., Hogg-Johnson S., and Bombardier C. Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol 50 (1997) 79-93
57. Husted J.A., Cook R.J., Farewell V.T., and Gladman D.D. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 53 (2000) 459-468
58. Terwee C.B., Dekker F.W., Wiersinga W.M., Prummel M.F., and Bossuyt P.M. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res 12 (2003) 349-362
59. El Moussaoui R., Opmeer B.C., Bossuyt P.M., Speelman P., de Borgie C.A., and Prins J.M. Development and validation of a short questionnaire in community acquired pneumonia. Thorax 59 (2004) 591-595
60. Norman G.R., Wyrwich K.W., and Patrick D.L. The mathematical relationship among different forms of responsiveness coefficients. Qual Life Res 16 (2007) 815-822
61. Wada T., Sasaki M., Kataoka H., Tanida S., Itoh K., Ogasawara N., et al. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 21 Suppl 2 (2005) 2-9
62. Juniper E.F., Norman G.R., Cox F.M., and Roberts J.N. Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir J 18 (2001) 38-44
63. Schünemann H.J., Goldstein R., Mador M.J., Mckim D., Itoh K., Ogasawara N., et al. Do clinical marker states improve responsiveness and construct validity of the standard gamble and feeling thermometer: a randomized multi-center trial in patients with chronic respiratory disease. Qual Life Res 15 (2006) 1-14
64. Puhan M.A., Guyatt G.H., Montori V.M., Bhandari M., Devereaux P.J., Griffith L., et al. The standard gamble demonstrated lower reliability than the feeling thermometer. J Clin Epidemiol 58 (2005) 458-465